CVD
35
1
2
25
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 35 trials
100.0%
+13.5% vs benchmark
17%
6 trials in Phase 3/4
16%
4 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (35)
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research Platforms
Theoretically Informed Behavioral Intervention
Hoosier Sport: Refining and Implementing a Sustainable Campus-Community Partnership in Rural Indiana
Hoosier Sport Re-Social: A Biobehavioral Intervention in Rural Indiana
Copenhagen Comorbidity in HIV Infection Study
HEARTWISE - P-CARDIAC for Chinese: Population-based Study
Evaluation of the AIVARIX in Detecting Signs C 1-2 Classes of CVD
EEG/MECG/EMG Evaluating the Severity of Aortic Stenosis, Heart Failure and Ischemic Stroke Through an Artificial Intelligenceassisted System.
Diabetes Prevention Program Outcomes Study
The Geneva Covid-19 CVD Study
Omega (n)-3 PUFA Enriched Beef & Health Outcomes.
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.
Understanding the Effect of Metformin on Corus CAD (or ASGES)
Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)